AzTrials
AzTrials

Preterm BirthNCT05515211

Diagnostic Accuracy of Foot Length in Predicting Preterm and Low Birth Weight Using Ultrasound Dating as The Gold Standard in a Rural District of Pakistan

An observational study of Preterm Birth and Low Birth Weight, run by Aga Khan University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: The burden of preterm and low birth weight babies (LBW) is high in low- and middle-income countries (LMICs). Therefore, assessment of gestational age (GA) and birth weight is important. Read more about this study

Who is it for?
Ages 0 to 48 hours
Conditions the study is for
Preterm Birth, Low Birth Weight
What is being tested?
Foot length
How many people
336 participants
Where
1 sitePakistan
Study dates
7 Nov 2022to 13 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 48 hours
  • All sexes
  • No healthy volunteers
  • Child

Study population: Singleton alive newborns

Who may be able to join

  • All livebirth singleton babies
  • Having first-trimester ultrasound for gestational age
  • Birth weight measured within 48 hours of birth

Who cannot join

  • Stillbirths
  • Multiple pregnancies
  • Gross congenital malformations such as neural tube defects, omphalocele, etc.,
  • Club foot
  • Pregnant women whose ultrasound dating differs between sonographers and senior radiologists

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Community of Thatta

    Thatta, Sindh, 73130

Other trials in Pakistan

About this study

Background:

The burden of preterm and low birth weight babies (LBW) is high in low- and middle-income countries (LMICs). Therefore, assessment of gestational age (GA) and birth weight is important. The GA is assessed using a reliable last menstrual period (LMP), measuring fundal height, using ultrasound for dating, or postnatally using Ballard, Dubowitz, or Eregie scores. However, each method has some limitations. Pregnant women in LMIC are not able to recall LMP and are also unreliable when menstrual cycles are irregular, fundal height is often imprecise and subject to variation due to observer bias, uterine pathologies, abdominal obesity, amniotic fluid volume, fetal position, and ultrasound in a rural setting is often unreliable because lack of trained sonologist, power failures, and maintenance of ultrasound machine. Post-natal GA scoring is also lengthy, subjective, and time-consuming. Similarly, determining birth weight has many challenges. In Thatta, weighing scales are only available in health facilities, therefore, birth weight is available for babies born in the health facilities. Furthermore, even where weighing scales are available, the calibration and maintenance are not without challenges, especially in the extremely hot climate. In the majority of studies, foot length has been validated for determining GA and birth weight, with LMP serving as the gold standard, which has limitations in our population. In a meta-analysis on the diagnostic accuracy of foot length to identify preterm and LBW, researchers emphasized the need for studies using high-quality ultrasound as a reference standard for early dating. Hence, there is a need to develop a simple and effective method of GA and birth weight that healthcare providers of all levels including mid-level healthcare workers in remote areas can use with reasonable accuracy.

Read more

Objectives of the study The primary objectives of the study are to determine the diagnostic accuracy of foot length in predicting GA and low birth weight using ultrasound conducted between 6-20 weeks for the predicted estimated date of delivery (EDD) as the gold standard.

Secondary objectives of the study are, 1) to develop the regression equations that predict gestational age and low birth weight using foot length, 2) to assess the use of foot length measurement as a screening tool to identify LBW or preterm infants in a community-based setting, and 3) to develop percentile charts of foot length for gestational age and low birth weight

Methods:

This test validation study will be conducted in Global Network's Maternal and Newborn Health Registry catchment area. All live birth singleton babies who have a first-trimester ultrasound for gestational age and birth weight within 48 hours of birth will be included in this study. Stillbirths, multiple pregnancies, gross congenital malformations such as neural tube defects, omphalocele, etc., club foot, and babies with chromosomal abnormalities such as Down syndrome that make measuring foot length difficult, will be excluded from the study. Gestational age will be assessed using ultrasound between 6-20 weeks of gestation by a trained sonographer working in the registry. Neonatal assessment having neuromuscular, and physical signs will be conducted by the research assistants (RA). RA will be taking anthropometric measurements such as birth weight using calibrated weighing scales, foot length, mid-upper arm circumference, and fronto-occipital circumference.

The data will be entered in Epicollect data five. Sensitivity, specificity, positive \& negative predictive value, likelihood ratios, and diagnostic accuracy will be done using different cut-offs of foot length against ultrasound estimated gestational age and birth weight. Receivers operating characteristics (ROC) curves will be generated to identify the optimal cut-off point for foot length taken within 24 hours of birth for identification of prematurity and LBW (based on first-trimester ultrasound) with ≥80% sensitivity. Linear regression will be done for estimating predictive values of foot length by GA. Pentile charts for foot length (FL) against GA will be derived. Bland Altman's analyses will identify and quantify any biases inherent to the tool.

Public health implications:

If these equations predict gestational age and birth weight with accuracy, an android-based application can be developed for health care providers (HCP) who simply measure foot length and enter it into the application to identify preterm \&/or low birth weight along with referred guidelines for early treatment. This is one step closer to Every Newborn Action Plan's goal of lowering neonatal mortality to 12/1000 LB by 2030.

Being tested
Foot length
Keywords
Gestational age, birth weight, Diagnostic accuracy, Regression equation, Correlation
Medical subject headings
Premature Birth, Birth Weight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Foot lengthDiagnostic test

    Foot length will be measured from the midpoint of the heel to the longest toe.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic accuracy of foot length for preterm baby

    Diagnostic accuracy defined as sensitivity, specificity, predictive values, likelihood ratios

    Measured: Within 48 hours of birth

  2. Diagnostic accuracy of foot length for low birth weight baby

    Diagnostic accuracy defined as sensitivity, specificity, predictive values, likelihood ratios

    Measured: Within 48 hours of birth

Secondary outcomes (1)
  1. Small for gestational age

    Birth weigh less than 10th centile for age and sex

    Measured: Within 48 hours of birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2022
  2. Study start7 Nov 2022
  3. Primary completion30 Jun 2023
  4. Study completion13 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
336 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05515211
Sponsor's protocol ID
2022-7421-21580
Status last verified
Jul 2023
First submitted
23 Aug 2022
Last updated
14 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: After the publication of the main papers, data could be made publicly available to other researchers.

Publications

  • Tikmani SS, Brown N, Inayat Ali A, Martensson A, Saleem S, Martensson T. Postnatal foot length measurement as a proxy to identify low birth weight for frontline health workers in rural Sindh Province, Pakistan: a diagnostic accuracy study. BMJ Open. 2024 Dec 26;14(12):e089153. doi: 10.1136/bmjopen-2024-089153.

    PubMed 39730154
  • Tikmani SS, Brown N, Inayat A, Martensson A, Saleem S, Martensson T. Diagnostic accuracy of foot length measurement for identification of preterm newborn in rural Sindh, Pakistan. BMJ Paediatr Open. 2024 Jan 24;8(1):e002316. doi: 10.1136/bmjpo-2023-002316.

    PubMed 38267220

Questions about this trial

What is this clinical trial studying?

An observational study of Preterm Birth and Low Birth Weight, run by Aga Khan University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic accuracy of foot length for preterm baby (time frame: Within 48 hours of birth). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05515211, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in